We are live on ! Find out more
GLSI icon

Greenwich LifeSciences
GLSI

35 hedge funds and large institutions have $19.4M invested in Greenwich LifeSciences in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 14 increasing their positions, 8 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 8

0.22% less ownership

Funds ownership: 6.29% → 6.07% (-0.22%)

3% less funds holding

Funds holding: 36 → 35 (-1)

14% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 7

39% less capital invested

Capital invested by funds: $31.9M → $19.4M (-$12.5M)

Holders
35
Holders Change
-1
Holders Change %
-2.78%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
14
Reduced
8
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$1.19M
2
Renaissance Technologies
Renaissance Technologies
New York
+$1M
3
Ameriprise
Ameriprise
Minnesota
+$755K
4
BlackRock
BlackRock
New York
+$673K
5
Marshall Wace
Marshall Wace
United Kingdom
+$593K

Top Sellers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
-$5.79M
2
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$1.13M
3
TEE
Tibra Equities Europe
United Kingdom
-$496K
4
SW
SkyOak Wealth
Michigan
-$289K
5
OMC
Old Mission Capital
Illinois
-$287K
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
$38K -$6.89K -206 -12%
Citigroup
27
Citigroup
New York
$25K -$20.2K -605 -37%
TRCT
28
Tower Research Capital (TRC)
New York
$22K +$21.7K +649 +263%
SO
29
STRS Ohio
Ohio
$21K – – –
NFSG
30
Newbridge Financial Services Group
Florida
$12K – – –
Legal & General Group
31
Legal & General Group
United Kingdom
$10K – – –
AIP
32
Ameritas Investment Partners
Nebraska
$8K – – –
S
33
SignatureFD
Georgia
$6K -$10.2K -305 -55%
NSIM
34
North Star Investment Management
Illinois
$1K – – –
Osaic Holdings
35
Osaic Holdings
Arizona
$1K +$1.67K +50 New
Invesco
36
Invesco
Georgia
– -$5.79M -148,087 Closed
Bank of Montreal
37
Bank of Montreal
Ontario, Canada
– -$1.13M -28,229 Closed
TEE
38
Tibra Equities Europe
United Kingdom
– -$496K -12,700 Closed
SW
39
SkyOak Wealth
Michigan
– -$289K -7,388 Closed
OMC
40
Old Mission Capital
Illinois
– -$287K -7,358 Closed
State of Wisconsin Investment Board
41
State of Wisconsin Investment Board
Wisconsin
– -$203K -5,200 Closed
DWA
42
Dorsey Wright & Associates
California
– -$44K -1,118 Closed
1
2

GLSI Hedge Fund Activity: Q4 2021 in Review

35 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Greenwich LifeSciences (GLSI) for Q4 2021, worth a combined $19.4M — down 39% from $31.9M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of GLSI and 6 opened new positions — a net loss of 1 holder — while 8 trimmed existing stakes and 14 added.

The largest buyer was Morgan Stanley, adding an estimated $1.19M. The largest seller was Invesco, exiting entirely with an estimated $5.79M sold.

  • 35 institutional investors held Greenwich LifeSciences (GLSI) as of Q4 2021, down from 36 in Q3 2021.
  • Funds reported $19.4M of Greenwich LifeSciences stock for Q4 2021, down 39% quarter-over-quarter.
  • 6 funds opened new Greenwich LifeSciences positions in Q4 2021 and 7 closed out, a net change of -1 holder.
  • The largest Greenwich LifeSciences buyer in Q4 2021 was Morgan Stanley, an estimated $1.19M added.
  • The largest Greenwich LifeSciences seller in Q4 2021 was Invesco, an estimated $5.79M sold.

Based on aggregated 13F filings for Q4 2021.